Document is current
Any future updates will be listed below
-
Authors
Odeyemi, Yewande E.
LeMahieu, Allison M.
Barreto, Erin F.
Yadav, Hemang
Gajic, Ognjen
Schulte, Phillip
-
Funding
Funding for this research was provided by:
National Institute of Health (K23HL168212, K23HL151671)
- License Information
-
More Information
Article History
Received: 13 June 2025
Accepted: 13 September 2025
First Online: 25 November 2025
Declarations
:
: The Mayo Clinic Institutional Review Board (IRB) approved this study prior to its initiation (IRB number: 17-011140, modification approval date: June 2021, Title: Concordant versus discordant corticosteroid use with markers of inflammation in critically ill patients with pneumonia and ARDS). Informed consent was waived, and procedures were followed in accordance with the ethical standards of the Mayo Clinic IRB and with the Helsinki Declaration of 1975.
: The authors declare no competing interests.
